Literature DB >> 18046444

Low MCL-1 mRNA expression correlates with prolonged survival in B-cell chronic lymphocytic leukemia.

L Véronèse, O Tournilhac, P Verrelle, F Davi, G Dighiero, E Chautard, R Veyrat-Masson, F Kwiatkowski, C Goumy, P Vago, P Travade, A Tchirkov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18046444     DOI： 10.1038/sj.leu.2405052

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

1.  LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia.

Authors:  Mohd Arifin Kaderi; Meena Kanduri; Anne Mette Buhl; Marie Sevov; Nicola Cahill; Rebeqa Gunnarsson; Mattias Jansson; Karin Ekström Smedby; Henrik Hjalgrim; Jesper Jurlander; Gunnar Juliusson; Larry Mansouri; Richard Rosenquist
Journal:  Haematologica       Date:  2011-04-20       Impact factor: 9.941

2.  An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737.

Authors:  Sayer Al-Harbi; Brian T Hill; Suparna Mazumder; Kamini Singh; Jennifer Devecchio; Gaurav Choudhary; Lisa A Rybicki; Matt Kalaycio; Jaroslaw P Maciejewski; Janet A Houghton; Alexandru Almasan
Journal:  Blood       Date:  2011-07-19       Impact factor: 22.113

3.  Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab.

Authors:  Farrukh T Awan; Neil E Kay; Melanie E Davis; Wenting Wu; Susan M Geyer; Nelson Leung; Diane F Jelinek; Renee C Tschumper; Charla R Secreto; Thomas S Lin; Michael R Grever; Tait D Shanafelt; Clive S Zent; Timothy G Call; Nyla A Heerema; Gerard Lozanski; John C Byrd; David M Lucas
Journal:  Blood       Date:  2008-11-13       Impact factor: 22.113

4.  Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation.

Authors:  C Spagnuolo; C Cerella; M Russo; S Chateauvieux; M Diederich; G L Russo
Journal:  Br J Cancer       Date:  2011-07-12       Impact factor: 7.640

Review 5.  Broad targeting of resistance to apoptosis in cancer.

Authors:  Ramzi M Mohammad; Irfana Muqbil; Leroy Lowe; Clement Yedjou; Hsue-Yin Hsu; Liang-Tzung Lin; Markus David Siegelin; Carmela Fimognari; Nagi B Kumar; Q Ping Dou; Huanjie Yang; Abbas K Samadi; Gian Luigi Russo; Carmela Spagnuolo; Swapan K Ray; Mrinmay Chakrabarti; James D Morre; Helen M Coley; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; William G Helferich; Xujuan Yang; Chandra S Boosani; Gunjan Guha; Dipita Bhakta; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; W Nicol Keith; Alan Bilsland; Dorota Halicka; Somaira Nowsheen; Asfar S Azmi
Journal:  Semin Cancer Biol       Date:  2015-04-28       Impact factor: 15.707

6.  Association of Bax Expression and Bcl2/Bax Ratio with Clinical and Molecular Prognostic Markers in Chronic Lymphocytic Leukemia.

Authors:  Ksenija Vucicevic; Vladimir Jakovljevic; Natasa Colovic; Natasa Tosic; Tatjana Kostic; Irena Glumac; Sonja Pavlovic; Teodora Karan-Djurasevic; Milica Colovic
Journal:  J Med Biochem       Date:  2016-05-09       Impact factor: 3.402

7.  Substituted 4-(thiazol-5-yl)-2-(phenylamino)pyrimidines are highly active CDK9 inhibitors: synthesis, X-ray crystal structures, structure-activity relationship, and anticancer activities.

Authors:  Hao Shao; Shenhua Shi; Shiliang Huang; Alison J Hole; Abdullahi Y Abbas; Sonja Baumli; Xiangrui Liu; Frankie Lam; David W Foley; Peter M Fischer; Martin Noble; Jane A Endicott; Chris Pepper; Shudong Wang
Journal:  J Med Chem       Date:  2013-01-25       Impact factor: 7.446

8.  Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells.

Authors:  Silvia Bruno; Bernardetta Ledda; Claudya Tenca; Silvia Ravera; Anna Maria Orengo; Andrea Nicola Mazzarello; Elisa Pesenti; Salvatore Casciaro; Omar Racchi; Fabio Ghiotto; Cecilia Marini; Gianmario Sambuceti; Andrea DeCensi; Franco Fais
Journal:  Oncotarget       Date:  2015-09-08

9.  Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1.

Authors:  Rebecca Voltan; Erika Rimondi; Elisabetta Melloni; Paola Gilli; Valerio Bertolasi; Fabio Casciano; Gian Matteo Rigolin; Giorgio Zauli; Paola Secchiero
Journal:  Oncotarget       Date:  2016-04-05

10.  Berberine affects mitochondrial activity and cell growth of leukemic cells from chronic lymphocytic leukemia patients.

Authors:  Silvia Ravera; Fabio Ghiotto; Claudya Tenca; Elena Gugiatti; Sara Santamaria; Bernardetta Ledda; Adalberto Ibatici; Giovanna Cutrona; Andrea N Mazzarello; Davide Bagnara; Martina Cardillo; Daniela Zarcone; Zbigniew Darzynkiewicz; Ermanno Ciccone; Franco Fais; Silvia Bruno
Journal:  Sci Rep       Date:  2020-10-05       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.